Abstract
Intrahepatic cholestasis in pregnancy (ICP) represents, depending on its severity, a serious risk for the fetus. Those cases with unusually high bile acid levels may be resistant to pharmaceutical treatment and can be treated with plasma exchange or albumin dialysis. However, the success rate of these therapeutic options and the factors influencing therapeutic response are unknown. Furthermore, if these options fail to improve ICP and serum bile acid levels are very high (>200 μm/L), there are no clear recommendations when delivery should be planned. Here, we report a patient with severe ICP resistant to both therapeutic plasma exchange and albumin dialysis. Caesarean section was performed at 32 weeks of gestation followed by rapid remission of ICP.
Reference30 articles.
1. Obstetric cholestasis, outcome with active management: a series of 70 cases
2. Kenyon AP , Girling JC , on behalf of the Royal College of Obstetricians and Gynaecologists . Obstetric cholestasis. Green-top guideline No. 43, 2011. Available: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_43.pdf
3. Eppinger H . Die Leberkrankheiten. Berlin: Springer Verlag, 1937.
4. Recurrent jaundice of pregnancy
5. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy;Reyes;Gastroenterol Clin North Am,1992
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Albumin-human/azathioprine;Reactions Weekly;2022-10-22